Amplicon-Dependent CCNE1 Expression Is Critical for Clonogenic Survival after Cisplatin Treatment and Is Correlated with 20q11 Gain in Ovarian Cancer-Reference-Cited by-同舟云学术

Amplicon-Dependent CCNE1 Expression Is Critical for Clonogenic Survival after Cisplatin Treatment and Is Correlated with 20q11 Gain in Ovarian Cancer

Published:2010-11-12 Issue:11 Volume:5 Page:e15498
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Etemadmoghadam Dariush,George Joshy,Cowin Prue A.,Cullinane Carleen,Kansara Maya,Gorringe Kylie L.,Smyth Gordon K.,Bowtell David D. L.,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference44 articles.

1. First-line treatment of advanced ovarian cancer: current research and perspectives.;C Marchetti;Expert Rev Anticancer Ther,2010

2. Cisplatin: mode of cytotoxic action and molecular basis of resistance.;ZH Siddik;Oncogene,2003

3. Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas.;D Etemadmoghadam;Clin Cancer Res,2009

4. Analysis of gene amplification and prognostic markers in ovarian cancer using comparative genomic hybridization for microarrays and immunohistochemical analysis for tissue microarrays.;D Mayr;Am J Clin Pathol,2006

5. Cyclin E expression is a significant predictor of survival in advanced, suboptimally debulked ovarian epithelial cancers: a Gynecologic Oncology Group study.;J Farley;Cancer Res,2003

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Compartment-specific multiomic profiling identifies SRC and GNAS as candidate drivers of epithelial-to-mesenchymal transition in ovarian carcinosarcoma;British Journal of Cancer;2023-12-14

2. Heterogeneity and treatment landscape of ovarian carcinoma;Nature Reviews Clinical Oncology;2023-10-02

3. Could cannabinoids provide a new hope for ovarian cancer patients?;Pharmacology Research & Perspectives;2023-08

4. Amplified therapeutic targets in high-grade serous ovarian carcinoma – a review of the literature with quantitative appraisal;Cancer Gene Therapy;2023-02-20

5. The Roles of Exosomes in Ovarian Cancer Chemo-resistance;Journal of Cancer;2023